Home » Topics » Regulatory

Regulatory
RSS

FDA approves Halaven in new indication

Jan. 29, 2016

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

SK Chemicals' SKY Cellflu Quadrivalent approved in South Korea

Dec. 29, 2015

FDA approves AstraZeneca's Zurampic for hyperuricemia in gout

Dec. 23, 2015

FDA approves Uptravi for pulmonary arterial hypertension

Dec. 22, 2015

FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma

Dec. 21, 2015

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015